Literature DB >> 3135393

Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus.

P M Ford1, S E Ford, D P Lillicrap.   

Abstract

Two cases of systemic lupus erythematosus with hemodynamically significant mitral valve dysfunction and associated lupus anticoagulant are reported. Both patients underwent valve replacement and both had thrombus formation on the mitral valve, one pre- and the other postoperatively. Both patients suffered a number of extracardiac thromboses at different times in the course of their illness. The contribution of the lupus anticoagulant to the thrombotic problems, and its possible relationship to the pathogenesis of Libman-Sacks endocarditis are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3135393

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Mitral valve plasty in systemic lupus erythematosus in the setting of antiphospholipid syndrome.

Authors:  M Yoshida; Y Sasako; J Kobayashi; K Minatoya; K Bando; S Kitamura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-06

2.  Heart valve disease in systemic lupus erythematosus. Role of antiphospholipid antibodies.

Authors:  O Meyer; M Golstein; P Nicaise; C Labarre; M F Kahn
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 3.  Coagulation abnormalities and cerebral infarction.

Authors:  M Greaves
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

4.  Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients.

Authors:  R Cervera; J Font; C Paré; M Azqueta; F Pérez-Villa; A López-Soto; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

5.  A case of tricuspid valve non-bacterial thrombotic endocarditis presenting as pulmonary embolism in a patient with antiphospholipid antibody syndrome.

Authors:  Dileep Unnikrishnan; Nasreen Shaikh; Ahmad Sharayah; Chandler Patton
Journal:  BMJ Case Rep       Date:  2018-03-13

6.  Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome.

Authors:  R A Asherson; P Merry; J F Acheson; E N Harris; G R Hughes
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

7.  Recurrent cerebral infarction and the antiphospholipid syndrome: effect of intravenous gammaglobulin in a patient with systemic lupus erythematosus.

Authors:  G Sturfelt; F Mousa; H Jonsson; O Nived; H Thysell; F Wollheim
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 8.  Diagnosis and pathogenesis of CNS lupus.

Authors:  A P van Dam
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

9.  Sub-clinical systemic lupus erythematosus presenting with acute myocarditis.

Authors:  K Sandrasegaran; C W Clarke; V Nagendran
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

10.  Thrombosis in systemic lupus erythematosus: a French collaborative study.

Authors:  M A Montes de Oca; M C Babron; O Blétry; M Broyer; V Courtecuisse; J L Fontaine; C Loirat; J P Méry; P Reinert; B Wechsler
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.